Bittner R, Beger H G, Kraas E, Gögler H
Arch Surg. 1976 Aug;111(8):850-3. doi: 10.1001/archsurg.1976.01360260018003.
In peripheral and portal venous blood, the immunoreactive insulin (IRI) and glucose levels in response to orally and intravenously administered glucose were measured in 14 patients with selective gastric vagotomy and pyloroplasty (SGV+P) and in 17 control subjects with other abdominal surgery. After intravenously administered glucose, the insulin and the glucose levels were nearly identical in both groups. After orally administered glucose, there were remarkable differences. Despite their early postoperative situations, and in contrast to the control patients, the SGV+P subjects showed no hyperglycemia. The measurements of IRI in the portal vein suggested that in SGV+P patients, the response of the islet cells is accelerated. In patients with SGV+P, the release of an insulinotropic intestinal factor and the preserved vagal innervation of the pancreas may be responsible for the accelerated insulin response of the undisturbed glucose tolerance.
对14例接受选择性胃迷走神经切断术和幽门成形术(SGV+P)的患者以及17例接受其他腹部手术的对照受试者,测量了外周静脉血和门静脉血中口服及静脉注射葡萄糖后免疫反应性胰岛素(IRI)和葡萄糖水平。静脉注射葡萄糖后,两组的胰岛素和葡萄糖水平几乎相同。口服葡萄糖后,两组之间存在显著差异。尽管处于术后早期,与对照患者相反,SGV+P组患者未出现高血糖。门静脉IRI测量结果表明,SGV+P患者的胰岛细胞反应加快。在SGV+P患者中,促胰岛素肠因子的释放以及胰腺保留的迷走神经支配可能是葡萄糖耐量未受干扰情况下胰岛素反应加快的原因。